{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T18:10:01Z","timestamp":1683655801701},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Surgical Oncology"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1007\/bf02523626","type":"journal-article","created":{"date-parts":[[2006,11,7]],"date-time":"2006-11-07T14:42:48Z","timestamp":1162910568000},"page":"186S-191S","source":"Crossref","is-referenced-by-count":0,"title":["The staging of malignant melanoma and the florida melanoma trial"],"prefix":"10.1007","volume":"11","author":[{"given":"Douglas S.","family":"Reintgen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Jakub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange","family":"Pendas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gray","family":"Swor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemary","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Shivers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02523626_CR1","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/1097-0142(19930515)71:10<2995::AID-CNCR2820711018>3.0.CO;2-P","volume":"71","author":"L Ryan","year":"1993","unstructured":"Ryan L, Kramar A, Borden E. Prognostic factors in metastatic melanoma.Cancer 1993;71:2995\u20133005.","journal-title":"Cancer"},{"key":"BF02523626_CR2","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","volume":"19","author":"CM Balch","year":"2001","unstructured":"Balch CM, Soong SJ, Gershenwald J et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the new AJCC melanoma staging system.J Clin Oncol 2001;19:3622\u201334.","journal-title":"J Clin Oncol"},{"key":"BF02523626_CR3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00000478-198808000-00002","volume":"12","author":"AJ Cochran","year":"1988","unstructured":"Cochran AJ, Wen DR, Morton DL. Occult tumor cells in lymph nodes of patients with pathological stage I melanoma: an immunohistological study.Am J Surg Pathol 1988;12:612\u20138.","journal-title":"Am J Surg Pathol"},{"key":"BF02523626_CR4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","volume":"127","author":"DL Morton","year":"1992","unstructured":"Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma.Arch Surg 1992;127:392\u20139.","journal-title":"Arch Surg"},{"key":"BF02523626_CR5","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10434-001-0766-1","volume":"8","author":"S Dessureault","year":"2001","unstructured":"Dessureault S, Soong SJ, Ross MI, et al. Improved staging of node-negative patients with intermediate to thick melanomas (>1.0 mm) with the use of lymphatic mapping and sentinel lymph node biopsy.Ann Surg Oncol 2001;8:749\u201351.","journal-title":"Ann Surg Oncol"},{"key":"BF02523626_CR6","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/archsurg.1991.01410360025005","volume":"126","author":"R Heller","year":"1991","unstructured":"Heller R, Wasselle J, Becker J, et al. The detection of submicroscopic lymph node metastases in patients with malignant melanoma.Arch Surg 1991;126:1455\u201360.","journal-title":"Arch Surg"},{"key":"BF02523626_CR7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000637-199201000-00019","volume":"28","author":"R Heller","year":"1992","unstructured":"Heller R, Becker J, Wasselle J, et al. Detection of occult lymph node metastases in malignant melanoma.Ann Plastic Surg 1992; 28:74\u20137.","journal-title":"Ann Plastic Surg"},{"key":"BF02523626_CR8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/j.1098-2388.1993.tb00022.x","volume":"9","author":"R Heller","year":"1993","unstructured":"Heller R, King B, Baekey P, et al. The identification of submicroscopic lymph node metastases in patients with malignant melanoma.Semin Surg Oncol 1993;9:285\u20139.","journal-title":"Semin Surg Oncol"},{"key":"BF02523626_CR9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/00000658-199412000-00010","volume":"220","author":"X Wang","year":"1994","unstructured":"Wang X, Heller R, Van Voorhis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma.Ann Surg 1994;220:768\u201375.","journal-title":"Ann Surg"},{"key":"BF02523626_CR10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1097-0142(19900815)66:4<765::AID-CNCR2820660428>3.0.CO;2-M","volume":"66","author":"KH Cho","year":"1990","unstructured":"Cho KH, Hashimoto K, Taniguchi Y, et al. Immunohistochemical study of melanocytic nevus and malignant melanoma with monoclonal antibodies against S-100 subunits.Cancer 1990;66:765\u201371.","journal-title":"Cancer"},{"key":"BF02523626_CR11","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jama.280.16.1410","volume":"280","author":"SC Shivers","year":"1998","unstructured":"Shivers SC, Wang X, Li W, et al. Molecular staging of malignant melanoma: correlation with clinical outcome.JAMA 1998;280:1410\u20135.","journal-title":"JAMA"},{"key":"BF02523626_CR12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/0140-6736(91)92100-G","volume":"338","author":"B Smith","year":"1991","unstructured":"Smith B, Selby P, Southgate J, et al. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction.Lancet 1991;338:1227\u20139.","journal-title":"Lancet"},{"key":"BF02523626_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","volume":"14","author":"JM Kirkwood","year":"1996","unstructured":"Kirkwood JM, Strawderman MH, Ernstoff MS, et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group EST 1684 Trial.J Clin Oncol 1996;14:7\u201317.","journal-title":"J Clin Oncol"},{"key":"BF02523626_CR14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00000658-200006000-00003","volume":"231","author":"W Li","year":"2000","unstructured":"Li W, Stall A, Shivers SC, et al. Clinical relevance of molecular staging for melanomal.Ann Surg 2000;231:795\u2013803.","journal-title":"Ann Surg"},{"key":"BF02523626_CR15","unstructured":"Shivers S, Hoffman S, Lin J, et al. Low specificity for detection of sentinel node micrometastases by a nested RT-PCR assay for tyrosinase in melanoma patients [abstract]. Paper presented at: Proceedings of the 54th Annual Cancer Symposium, Society of Surgical Oncology; March 15\u201318, 2001; Washington, DC."},{"key":"BF02523626_CR16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1056\/NEJM197709222971202","volume":"297","author":"U Veronesi","year":"1977","unstructured":"Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage I melanoma of the limbs.N Engl J Med 1977;297:627\u201331.","journal-title":"N Engl J Med"},{"key":"BF02523626_CR17","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0025-6196(12)62768-2","volume":"61","author":"FH Sim","year":"1986","unstructured":"Sim FH, Taylor WF, Pritchard DJ, et al. Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study.Mayo Clin Proc 1986;61:697\u2013701.","journal-title":"Mayo Clin Proc"},{"key":"BF02523626_CR18","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1200\/JCO.2000.18.12.2444","volume":"18","author":"J Kirkwood","year":"2000","unstructured":"Kirkwood J, Ibrahim JG, Sondak V, et al. High- and low-dose interferon alfa 2-b in high-risk melanoma: first analysis of Intergroup Trial E1690\/S9111\/C9190.J Clin Oncol 2000;18:2444\u201358.","journal-title":"J Clin Oncol"},{"key":"BF02523626_CR19","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1200\/JCO.2001.19.9.2370","volume":"19","author":"JM Kirkwood","year":"2001","unstructured":"Kirkwood JM, Ibrahim J, Sosman JA, et al. High- and low-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with GM2-KLH\/QS-21 vaccine in patients with resected Stage IIB-III melanoma: results of intergroup trial E1694\/S9512\/C509801.J Clin Oncol 2001;19:2370\u201380.","journal-title":"J Clin Oncol"},{"key":"BF02523626_CR20","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1200\/JCO.1996.14.7.2091","volume":"14","author":"B Mellado","year":"1996","unstructured":"Mellado B, Colomer D, Castel T, et al. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: Association with clinical stage and prognosis.J Clin Oncol 1996;14:2091\u20137.","journal-title":"J Clin Oncol"},{"key":"BF02523626_CR21","unstructured":"McMasters KM, Edwards, M, Ross M, et al. Frequency of nonsentinel lymph node metastases in melanoma [abstract]. Paper presented at: Proceedings of the 54th Annual Cancer Symposium, Society of Surgical Oncology; March 15\u201318, 2001; Washington, DC."},{"key":"BF02523626_CR22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10434-999-0232-z","volume":"6","author":"SC Bieligk","year":"1999","unstructured":"Bieligk SC, Ghossein R, Bhattacharya S, et al. Detection of tyrosinase mRNA by reverse transcription polymerase chain reaction in melanoma sentinel nodes.Ann Surg Oncol 1999;6:225\u20136.","journal-title":"Ann Surg Oncol"},{"key":"BF02523626_CR23","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1200\/JCO.1999.17.10.3238","volume":"17","author":"PJ Bostick","year":"1999","unstructured":"Bostick PJ, Morton DL, Turner RR, et al. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.J Clin Oncol 1999;17:3238\u201344.","journal-title":"J Clin Oncol"},{"key":"BF02523626_CR24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1072-7515(98)00138-0","volume":"187","author":"JS Goydos","year":"1998","unstructured":"Goydos JS, Ravikumar TS, Germino FJ, et al. Minimally invasive stating of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction.J Am Coll Surg 1998;187:182\u20138.","journal-title":"J Am Coll Surg"},{"key":"BF02523626_CR25","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1200\/JCO.1999.17.8.2562","volume":"17","author":"BJ Curry","year":"1999","unstructured":"Curry BJ, Myers K, Hersey P. MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases.J Clin Oncol 1999; 17:2562\u201371.","journal-title":"J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02523626.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02523626\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02523626","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T17:36:13Z","timestamp":1683653773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02523626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":25,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["BF02523626"],"URL":"https:\/\/doi.org\/10.1007\/bf02523626","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}